ADVERTISEMENT

From the Desk of the CEO

James Keagy
/ Categories: CEO Blog

Commemorating World AIDS Day

APhA stands with the global community today on the 35th commemoration of World AIDS Day. It’s an important opportunity to raise awareness about HIV infection, honor the lives affected by the epidemic, and commit to working toward eliminating HIV as a public health threat.

Although there have been significant advancements in treatment and management of HIV, the struggle to end this epidemic has been going on for too long. My heart goes out to those of you who have been touched by HIV and AIDS.

HHS has adopted a focused four-part plan to bring an end to the epidemic: diagnose all people with HIV as early as possible, treat people with HIV rapidly and effectively to reach sustained viral suppression, prevent new HIV transmissions by using proven interventions including PrEP and syringe services programs, and respond quickly to potential HIV outbreaks to get prevention and treatment services to people who need them.

Pharmacists play a key role in increasing access to HIV PrEP and PEP. Currently, 27 states allow pharmacists to prescribe PrEP and/or PEP independently under population-based collaborative practice agreements  or under statewide orders or protocols. However, only 14 of those states have payment pathways in place that enable pharmacists to be reimbursed by Medicaid and/or commercial insurance for their services associated with HIV care.

APhA has been leading advocacy efforts to expand the role of community pharmacies in HIV prevention and care through increased scope of practice and corresponding payment pathways. In this, we are partnering with representatives from the White House Office of National AIDS Policy (ONAP), NIH, CDC, HHS, the Elton John AIDS Foundation, and many others. APhA also served as a coalition partner in two summits to discuss opportunities and challenges to opening the door for pharmacist patient care services, particularly in communities that are most at risk for HIV infection.

We are proudly wearing red ribbons today in recognition of World AIDS Day, and we look forward to a day when HIV infection is no longer a public health threat.

My very best,
Michael

Previous Article Reflections on my recent trip to Kansas City
Next Article A New Year’s resolution
Print
4996
Please login or register to post comments.

Featured Post

Posted: Sep 29, 2026

Remembering Jack Schlegel, former APhA CEO

APhA mourns the passing of former CEO John F. “Jack” Schlegel, PharmD. His courageous leadership helped shape our association and strengthen pharmacy’s voice. Michael Hogue reflects on Jack’s legacy and the kindness he experienced firsthand.

All Posts

Posted: Oct 8, 2026

What Canada can teach us about the pharmacy team

In his latest blog, APhA CEO Michael Hogue explores how technology, pharmacy technicians, and modernized workflows can help transform pharmacy practice and enable pharmacists to focus on the patient care services only they are trained and licensed to provide. Drawing from a visit to a high-volume community pharmacy in Quebec, Hogue highlights a care model where pharmacists concentrate on medication management, clinical decision-making, and patient consultations, while technology and qualified technicians support dispensing operations.

Posted: Sep 29, 2026

Remembering Jack Schlegel, former APhA CEO

APhA mourns the passing of former CEO John F. “Jack” Schlegel, PharmD. His courageous leadership helped shape our association and strengthen pharmacy’s voice. Michael Hogue reflects on Jack’s legacy and the kindness he experienced firsthand.

Posted: Sep 17, 2026

We're all in this together

Following the passing of former APhA President R. David Cobb, APhA CEO Michael Hogue reflects on Cobb’s enduring leadership and his belief that pharmacy is strongest when its organizations work together.

Posted: Sep 14, 2026

Standard of Care Means Pharmacists Must Control Their Own Practice

As pharmacy practice continues to evolve, pharmacists must have the autonomy to exercise their professional judgment and make decisions based on the needs of their patients. In this blog, CEO Michael Hogue explains why pharmacists must control their own practice and why professional autonomy is essential to protecting patients and advancing the profession.

Posted: Sep 11, 2026

Remembering September 11, 2001

Like many of you, I remember exactly where I was when I learned that an airplane had been intentionally flown into the World Trade Center in New York. Standing behind the counter at Morgan City Drugs, I didn’t have access to a television. However, we did have a radio, and it wasn’t hard to find a station that was covering the real-time events that morning. When the second airplane hit, we all knew that this was no accident, but an intentional attack on the very freedom we hold dear.

Voices of APhA

Perspectives & Stories from Our Staff

Posted: Oct 23, 2026

Kratom’s risks deserve our attention

Brigid Groves, PharmD, MS, Vice President, Professional Affairs, APhA

A patient seeking relief may not recognize the risks of a product within easy reach. Brigid K. Groves, PharmD, MS, APhA’s Vice President, Professional Affairs, shares why kratom and concentrated 7-OH products deserve pharmacists’ attention and how a simple conversation can help protect patients from harm.

Posted: Jul 22, 2026

Congressional update: The hurry up and wait approach

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an update on the rapidly shrinking congressional calendar and what it means for key pharmacy priorities. He explores the opportunities and challenges facing legislation such as the Main Street Pharmacy Access Act and why time may be the biggest obstacle to advancing pharmacy policy this year.

Posted: Jun 3, 2026

The bill formerly known as ECAPS

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Guest Spotlights

Thought Leadership & Contributions from Industry Experts

Posted: Jul 2, 2026

Deprescribing has entered the payment era

Jennifer Pruskowski, PharmD, PhD, BCPS, BCGP and Sean M. Jeffery, PharmD, BCGP, FASCP, AGSF

For years, clinicians have known that deprescribing is clinically important. Every day, health care professionals identify unnecessary medications, reduce adverse drug events, prevent falls, minimize drug interactions, and help patients navigate medication burden.

Posted: Jun 10, 2026

Offer vaccines just as strongly as last year

Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, Managing Editor, IZ Express, Immunize.org

In a new guest blog from APhA, Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, encourages pharmacists to continue giving strong vaccine recommendations and reminds the profession that vaccines remain one of the safest and most effective tools to prevent serious illness and death.

Posted: Jun 8, 2026

The Importance of Motivational Interviewing and Patient Connection

Bruce A. Berger, PhD, Professor Emeritus, Auburn University Harrison College of Pharmacy

Fifteen years ago, William Villaume and I developed our sense making approach to motivational interviewing (MI) based on Brenda Dervin's sense making theory.

Advertisement
Advertisement
Advertisement
Advertisement